On May 5, 2026, Holdings A/S Novo reported a significant purchase of Avalyn Pharma Inc. (AVLN) stock. The entity acquired 555,555 shares at a price of $18.00 per share, representing a total investment of approximately $10 million.
This substantial insider buy comes shortly after other notable transactions by company insiders. Earlier in May, George Simeon and SR ONE CAPITAL MANAGEMENT, LLC made multiple purchases, and Carroll Jill also acquired shares. Such large-scale insider acquisitions are often interpreted as a strong vote of confidence in the company's future performance.